Fund Holdings — Enavate Sciences GP, LLC

Total Portfolio Value:
$132.72M
Total Bought:
$30.77M
Total Sold:
$0
Net Transaction:
+$30.77M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Immunome, Inc.(IMNM)3,478,2614,768,583+1,290,322$36.94M$32.09M24.18%-$4.85M
Zenas BioPharma, Inc.(ZBIO)3,761,3593,761,3590$30.81M$29.71M22.39%-$1.09M
Sionna Therapeutics, Inc.(SION)02,478,030+2,478,030$0$25.92M19.53%+$25.92M
CAMP4 THERAPEUTICS CORPORATION(CAMP)3,785,8023,785,8020$19.76M$15.14M11.41%-$4.62M
Upstream Bio, Inc.(UPB)2,459,7032,459,7030$40.44M$15.05M11.34%-$25.38M
Compass Therapeutics, Inc.(CMPX)7,788,1507,788,1500$11.29M$14.80M11.15%+$3.50M
Page 1 of 1
Enavate Sciences GP, LLC — 13F Holdings — Q1 2025 | TickerTrail